SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001600132-19-000057
Filing Date
2019-03-14
Accepted
2019-03-14 08:29:21
Documents
4
Effectiveness Date
2019-03-14

Document Format Files

Seq Description Document Type Size
1 S-8 s-8march2019.htm S-8 76126
2 EXHIBIT 5.1 s-8march2019exhibit51.htm EX-5.1 12284
3 EXHIBIT 23.2 s-8march2019exhibit232.htm EX-23.2 2872
4 mintznewlogo.jpg GRAPHIC 8872
  Complete submission text file 0001600132-19-000057.txt   104725
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-230256 | Film No.: 19679794
SIC: 2834 Pharmaceutical Preparations